Health · 47 views
Lower dementia risk seen with sodium-glucose cotransporter 2 in seniors 65+ with mood, psychotic disorders
Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is associated with a lower risk for dementia in older adults with mood and psychotic disorders, according to a study published online June 30 in JAMA Network Open.
AI Summary
Research has identified a potential link between the use of sodium-glucose cotransporter 2 inhibitors and a reduced risk of dementia in seniors aged 65 and older who also have mood or psychotic disorders. The study, which was published in JAMA Network Open, found that individuals in this demographic who used these inhibitors experienced a lower risk of dementia compared to those who did not use them.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Health system analysis reveals shift toward less invasive heart valve replacement among younger patientsContinue reading
- FDA Panel Largely Pans Trial Data for Myopia Eye DropsContinue reading
- Climate change is killing hundreds of thousands—a kidney specialist's concernsContinue reading
- AI-supported screening strategy could improve cervical cancer detection in low-resource settingsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow